Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on liver-directed cancer therapies, today announced the presentation of new subgroup analysis data from the FOCUS Phase ...

Delcath Systems, Inc. , an interventional oncology company focused on liver-directed cancer therapies, today announced the presentation of new subgroup analysis data from the FOCUS Phase 3 trial of ...

In the US pivotal trial, WRAPSODY achieved 89.8% target lesion primary patency at 6 monthsSOUTH JORDAN, Utah, Sept. 16, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: MMSI), a global leader of healthcare ...

CSA Medical, Inc., today announced multiple presentations at the European Respiratory Society (ERS) Congress in Vienna detailing new clinical science supporting Metered CryoSpray (MCS) with the ...

Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include BDX, MCK, COO and STAA.

The Congressional Black Caucus Foundation's Annual Legislative Conference panel on the Road to Health Equity discussed the ...

All across Chester County Hospital, there are examples of how state-of-the-art technology is redefining medicine. In ...

A large “de-escalation” trial suggests that tens of thousands of people annually may be able to rely on only chemotherapy and surgery to treat their illness. By Gina Kolata For some patients ...

Merit Medical has revealed positive six-month data from a trial investigating its endoprosthesis in dialysis patients who ...

Karen Knudsen, PhD, CEO of both the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network, will transition from the organizations. Dr. Knudsen "will ...